企業プロフィール
Viatris Inc. 株価・ニュース・カタリスト
- ティッカー:
- VTRS
- 取引所:
- NASDAQ
- セクター:
- Generics, Small Molecule Drugs
- 所在地:
- United States
株価パフォーマンス
16.23 USD (0.00%)
終値
最終更新: 2026年8月17日
18.3B USD
時価総額
株価変動の要因
As of Aug 17, 2026, VTRS was little changed and closed at $16.23. No new same-company headline was identified in the current news window.
企業概要
事業概要
Viatris is a global healthcare company formed from the combination of Mylan and Pfizer’s Upjohn business. Its portfolio spans generics, branded generics, and some specialty products, with a business model centered on scale and portfolio management.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Viatris has a global commercial footprint. It sits in generics and diversified pharmaceuticals rather than biotech.
ビジネスモデルの特徴
The company generates value through product volume, geographic breadth, and lifecycle management across a broad medicines portfolio. Investors watch margin discipline, product mix, and the company’s ability to stabilize revenue after the merger integration.
バイオ業界での位置付け
Viatris is outside biotech and closer to diversified pharma and generics. It matters to healthcare investors because its products are broadly used, but it is not a catalyst-heavy biotech stock.
今後のカタリスト
- Viatris’s near-term catalysts are biosimilar launches, portfolio simplification, and continued debt / capital-allocation progress. The next update will help show whether the company is moving from promise to a more de-risked stage of execution. Investors will care less about the label than about whether the platform can keep producing credible next steps.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。